Project measures / variables set:   Noll1   IgG2b

ID, description, units MPD:112617   IgG2b   immunoglobulin G2b (serum IgG2b) area under curve (AUC) post-infection   [AUC]  
influenza A (H1N1) virus study
Measures • post-infection:    • day 7    • day 10    • day 15    • day 29    • day 45
Data set, strains Noll1   CC RIX   46 strains     sex: f     age: 8-12 wks
Procedure immunoglobulin quantification
Comparisontimecourse but different cohorts
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options

Noll1 - immunoglobulin G2b (serum IgG2b) area under curve (AUC) post-infection





  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
post-infection 4 1038.3793 259.5948 229.1919 < 0.0001
post-infection:strain 36 250.3645 6.9546 6.1401 < 0.0001
Residuals 134 151.7754 1.1327
strain 9 166.942 18.5491 16.3767 < 0.0001

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDTreatmentMeasure / Variable Description PanelStrains
tested
SexAge
Noll1 112617 immunoglobulin quantification influenza A (H1N1) virus immunoglobulin G2b (serum IgG2b) area under curve (AUC) post-infection   [AUC]   day 7  IgG2b_d7 CC RIX 39 f 8-12 wks
Noll1 112618 immunoglobulin quantification influenza A (H1N1) virus immunoglobulin G2b (serum IgG2b) area under curve (AUC) post-infection   [AUC]   day 10  IgG2b_d10 CC RIX 39 f 8-12 wks
Noll1 112619 immunoglobulin quantification influenza A (H1N1) virus immunoglobulin G2b (serum IgG2b) area under curve (AUC) post-infection   [AUC]   day 15  IgG2b_d15 CC RIX 34 f 8-12 wks
Noll1 112620 immunoglobulin quantification influenza A (H1N1) virus immunoglobulin G2b (serum IgG2b) area under curve (AUC) post-infection   [AUC]   day 29  IgG2b_d29 CC RIX 25 f 8-12 wks
Noll1 112621 immunoglobulin quantification influenza A (H1N1) virus immunoglobulin G2b (serum IgG2b) area under curve (AUC) post-infection   [AUC]   day 45  IgG2b_d45 CC RIX 32 f 8-12 wks